Sorbonne Venture is a Paris-based venture capital firm backing early-stage French companies emerging from academic innovation, with a focus on deep tech, healthtech, biotechnology, medical devices and life sciences. The firm targets a €100M+ fund size and around 15 portfolio companies, with investments including Biomemory, EverZom, Polygon and Austral Dx.